APA (7th ed.) Citation

R, K., A, M., S, P., A, C., L, B., & M, P. (2020). Druggability of CRMP2 for Neurodegenerative Diseases. ACS chemical neuroscience, 11(17), 2492. https://doi.org/10.1021/acschemneuro.0c00307

Chicago Style (17th ed.) Citation

R, Khanna, Moutal A, Perez-Miller S, Chefdeville A, Boinon L, and Patek M. "Druggability of CRMP2 for Neurodegenerative Diseases." ACS Chemical Neuroscience 11, no. 17 (2020): 2492. https://doi.org/10.1021/acschemneuro.0c00307.

MLA (9th ed.) Citation

R, Khanna, et al. "Druggability of CRMP2 for Neurodegenerative Diseases." ACS Chemical Neuroscience, vol. 11, no. 17, 2020, p. 2492, https://doi.org/10.1021/acschemneuro.0c00307.